Loading...
XSHG
600998
Market cap3.54bUSD
Sep 22, Last price  
4.96CNY
1D
-0.60%
1Q
-0.80%
Jan 2017
-49.80%
IPO
-40.45%
Name

Jointown Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
P/E
9.97
P/S
0.16
EPS
0.50
Div Yield, %
5.01%
Shrs. gr., 5y
3.18%
Rev. gr., 5y
8.82%
Revenues
151.81b
+1.11%
13,048,102,60516,287,598,13618,957,708,89521,251,772,76424,838,678,87529,507,662,75733,438,049,66541,068,404,47849,589,246,31261,556,839,88573,942,894,40387,136,358,55399,497,077,396110,859,514,087122,407,434,023140,424,191,627150,139,846,735151,809,799,000
Net income
2.51b
+15.33%
159,783,448202,635,778297,891,827353,427,258374,134,158412,720,761477,927,812560,706,759694,534,909876,741,8151,445,510,1021,340,578,8241,726,549,4793,075,054,8232,448,334,1822,084,962,5392,174,042,8382,507,392,000
CFO
3.08b
-35.54%
65,952,703494,748,8270000138,468,5820435,955,993431,263,75201,222,023,1642,767,873,0483,443,884,1083,459,045,0573,986,228,1564,782,206,8203,082,502,072
Dividend
Jun 07, 20240.25 CNY/sh

Profile

Jointown Pharmaceutical Group Co., Ltd provides marketing, distribution, and logistics services for digital pharmaceutical businesses. It wholesales Chinese herbal medicines, Chinese patent medicines, chemical medicinal materials, chemical medicine preparations, antibiotic preparations, biochemical drugs, biological products, chemical raw materials, and medical toxic drugs. The company was founded in 1999 and is based in Wuhan, China.
URL
http://www.jztey.com
IPO date
Nov 02, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
151,809,799
1.11%
150,139,847
6.92%
140,424,192
14.72%
Cost of revenue
143,329,109
141,529,508
134,608,978
Unusual Expense (Income)
NOPBT
8,480,690
8,610,339
5,815,213
NOPBT Margin
5.59%
5.73%
4.14%
Operating Taxes
851,030
701,202
552,554
Tax Rate
10.03%
8.14%
9.50%
NOPAT
7,629,660
7,909,137
5,262,659
Net income
2,507,392
15.33%
2,174,043
4.27%
2,084,963
-14.84%
Dividends
(1,553,505)
(936,935)
(548,621)
Dividend yield
6.05%
3.42%
2.16%
Proceeds from repurchase of equity
(268,150)
(2,000,000)
BB yield
1.04%
7.30%
Debt
Debt current
9,935,749
10,121,827
12,025,505
Long-term debt
2,415,825
2,678,058
3,371,753
Deferred revenue
233,601
244,454
231,808
Other long-term liabilities
102,726
360,700
74,677
Net debt
(9,188,708)
(7,791,386)
(5,135,557)
Cash flow
Cash from operating activities
3,082,502
4,782,207
3,986,228
CAPEX
(975,419)
(1,048,815)
Cash from investing activities
(1,591,739)
(1,361,130)
1,487,695
Cash from financing activities
(2,499,693)
(2,236,976)
FCF
6,353,234
9,187,420
6,533,980
Balance
Cash
18,362,410
17,039,212
17,495,685
Long term investments
3,177,872
3,552,059
3,037,130
Excess cash
13,949,792
13,084,279
13,511,606
Stockholders' equity
27,235,607
22,098,097
20,892,295
Invested Capital
31,632,201
29,382,319
30,132,949
ROIC
25.01%
26.58%
17.00%
ROCE
18.46%
20.10%
13.20%
EV
Common stock shares outstanding
5,014,784
3,908,892
4,064,708
Price
5.12
-26.96%
7.01
12.16%
6.25
-11.47%
Market cap
25,675,694
-6.30%
27,401,330
7.86%
25,404,428
-7.94%
EV
24,608,727
25,103,771
26,297,006
EBITDA
9,337,940
9,385,284
6,551,496
EV/EBITDA
2.64
2.67
4.01
Interest
1,332,872
1,317,638
1,221,466
Interest/NOPBT
15.72%
15.30%
21.00%